Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ASP Isotopes To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in ASP Isotopes between October 30, 2024 and November 26, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIR ...

Dublin, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The "Prepared Meals Global Industry Guide 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global Prepared Meals market had total revenues of $134.49 billion in 2023, representing a compound annual growth rate (CAGR) of 6.5% between 2018 and 2023. Global Prepared Meals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). Th ...

Dublin, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The "Confectionery Global Industry Almanac 2019-2028" report has been added to ResearchAndMarkets.com's offering. The performance of the market is forecast to accelerate, with an anticipated CAGR of 6.4% for the five-year period 2023-2028, which is expected to drive the market to a value of $273.82 billion by the end of 2028. Global Confectionery industry profile provides top-line qualitative and quantitative summary information including: market share, Market size ...

Despite their differences, Nvidia (NASDAQ: NVDA) and Palantir (NASDAQ: PLTR) have much in common. Both stocks enjoy significant investor optimism, both companies have been major players in the ongoing artificial intelligence (AI) boom, and both firms might be extravagantly overvalued given their recent gains.To begin with, Nvidia started its staggering rise soon after the original public version of ChatGPT was launched in late 2022 and gained some $3 trillion in market capitalization. The last 12 months hav ...

Stock Performance - Liquidia Technologies Inc (LQDA) shares rallied 5 7% in the last trading session closing at $13 62 driven by higher trading volume compared to a typical session [1] - The stock has gained 12 7% over the past four weeks [1] Product Development - The stock price rise is likely due to anticipation of final FDA approval and launch of Yutrepia (treprostinil) inhalation powder in 2025 which received temporary FDA approval in 2023 [2] - Yutrepia is indicated for treating pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease [2] Financial Expectations - The company is expected to post a quarterly loss of $0 39 per share representing a year-over-year improvement of +7 1% [3] - Revenues are expected to be $5 13 million up 13 2% from the year-ago quarter [3] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days [4] Industry Comparison - Liquidia Technologies is part of the Zacks Medical - Biomedical and Genetics industry [4] - Puma Biotech (PBYI) another stock in the same industry closed the last trading session 0 3% higher at $2 98 and has returned 5 7% in the past month [4] - For Puma Biotech the consensus EPS estimate for the upcoming report has changed +50% over the past month to $0 14 representing a change of -54 8% from the year-ago quarter [5] Stock Ratings - Liquidia Technologies currently carries a Zacks Rank 2 (Buy) [4] - Puma Biotech currently has a Zacks Rank of 3 (Hold) [5]

Healthpeak Properties, Inc. (DOC) is well poised for growth given the solid demand for lab assets amid the increasing need for drug innovation and developments. The rise in senior citizens’ healthcare expenditure is expected to support its continuing care retirement community (CCRC) portfolio.Encouraging capital-recycling moves and efforts to bolster near-term liquidity bode well for long-term growth. However, competition from the industry players and substantial debt add to its woes.Last month, DOC’s opera ...

Have you been paying attention to shares of Brainsway Ltd. Sponsored ADR (BWAY) ? Shares have been on the move with the stock up 18.2% over the past month. The stock hit a new 52-week high of $11.09 in the previous session. Brainsway Ltd. Sponsored ADR has gained 17.2% since the start of the year compared to the -3.2% move for the Zacks Medical sector and the 17.1% return for the Zacks Medical - Products industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surpr ...

Taiwan Semiconductor Manufacturing (TSM 1.81%) has enjoyed a stellar run on the stock market in the past year, clocking gains of 87% as of this writing, and it looks like the foundry giant is set to deliver another terrific year to investors in 2025.Popularly known as TSMC, the company has seen its shares jump almost 4% following the release of its fourth-quarter 2024 results on Jan. 16. TSMC not only beat estimates but also issued solid guidance for the first quarter of 2025 that turned out to be better th ...

The USA, Japan, and China are the primary contributors to the growth of the global tuna peptides market, each displaying unique dynamics in demand and consumption. As consumers increasingly turn to marine-derived ingredients for their health, wellness, and cosmetic benefits, these countries are poised to lead the charge in shaping the market’s future trajectory.NEWARK, Del, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The global Tuna Peptides Industry generated sales of USD 973.4 million in 2024, marking a 4.8% year-o ...

Bonchon offers guests free limited edition tote and $13.99 meal specials for Lunar New Year Limited Edition Bonchon Tote Limited edition Bonchon branded tote designed to celebrate the upcoming Year of the Snake. Bonchon Lucky 3 Meal - Drumstick Dream A combo including two drumsticks and two potstickers with a choice of Bonchon's signature sauce, plus a Korean Donut for a sweet ending. Dallas, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bonchon, a global leader in Korean fried chicken, is ringing in the Lunar ...